Helios Meds Review

Helios Meds: a no-frills, low-price route to compounded GLP-1s

Helios Meds is a cash-pay telehealth shop built around one promise: get you on compounded semaglutide for as little as possible, without the membership upsells and coaching add-ons that pad other programs. Run out of Hockessin, Delaware, it pairs an online provider visit with discreet, complimentary shipping and a flat product price. If your goal is the lowest realistic monthly cost on compounded GLP-1 and you don't need labs, coaching, or insurance billing, Helios is worth a serious look. If you want hand-holding or a brand-name pen, it isn't built for you.

How the pricing actually works

Helios keeps it simple. Compounded semaglutide starts at $149.99 a month, which lands below the $170 category median and is genuinely among the cheaper entry prices for compounded GLP-1. The headline number isn't a teaser rate that jumps after month one — there's no promo gimmick here. Instead, what you see is a plan-length bundle: you can pay month to month, or commit to a three-, six-, or twelve-month supply up front for a lower effective monthly cost. The longer you prepay, the less you pay per month, but the trade-off is locking in cash before you know how your body responds.

Crucially, the price includes the things that nickel-and-dime you elsewhere. There's no separate consult fee, and shipping is complimentary. So the monthly figure is closer to your true out-of-pocket than at programs that bolt on a membership or visit charge on top of the medication.

What about tirzepatide?

Helios also offers compounded tirzepatide, starting at a mid-three-figure monthly rate. That's a real jump from the semaglutide price and noticeably steeper than some competitors' compounded tirzepatide. If tirzepatide is the molecule you want, price-shop it specifically — Helios is most compelling on the semaglutide side, where its low entry price is the whole selling point.

The medications and how they're dispensed

Everything Helios sells is compounded, not brand-name. A US board-certified physician reviews your information through an online visit, and if appropriate, writes a prescription that's filled by a compounding pharmacy and shipped to your door in discreet packaging. The product price buys the medication, the provider review, and the shipping as a single package.

Be clear-eyed about what compounded means: these are not FDA-approved finished products the way Wegovy or Zepbound are. Compounded semaglutide and tirzepatide are mixed by a pharmacy rather than manufactured and approved as branded drugs. Many patients choose them deliberately for the cost savings, but it's a different regulatory category, and you should understand that going in.

What genuinely sets Helios apart

Two things. First, the price discipline — a sub-$170 entry point on compounded semaglutide with the consult and shipping folded in is a real differentiator in a market where many providers quote a low medication price and then attach fees. Second, LegitScript approval. LegitScript independently vets telehealth and pharmacy operators for legal and safety compliance, and not every cheap compounded-GLP-1 site carries it. Combined with US board-certified physicians doing the prescribing, it's a meaningful trust signal for an otherwise lean, budget-focused operation. Helios also advertises a money-back guarantee, which is uncommon at this price tier — confirm the exact refund terms before you buy.

• Low entry price: compounded semaglutide from $149.99/month, under the $170 median
• No separate consult fee and complimentary shipping baked into the price
• LegitScript-approved with US board-certified physicians prescribing
• Money-back guarantee advertised — verify the fine print directly

Who should choose it — and who should skip it

Choose Helios if you're a confident, self-directed patient who mainly wants affordable compounded semaglutide and is comfortable managing your own dose titration and progress without a coach or nutritionist. The transparent, fee-free pricing rewards people who just want the medication and shipping handled cleanly.

Skip it if you want insurance to cover anything — Helios is strictly cash-pay and doesn't bill insurers. Skip it if you need a brand-name product, since only compounded options are available. And think twice if you live somewhere Helios may not serve: the company doesn't publish a state-by-state availability list, so you'll need to confirm it ships to your state before counting on it. People who want structured coaching, frequent lab monitoring, or a high-touch clinical relationship will also be happier with a fuller-service program.

Trust, safety, and medical oversight

On the oversight front, Helios checks the boxes that matter most for a compounded-GLP-1 seller: LegitScript approval, US board-certified physicians, and a required online provider review before anything ships. There are no FDA warning letters on file against it in our records, which is reassuring. We rate verification confidence as medium rather than high — mainly because the public state list isn't enumerated and Helios is a direct provider we vet from its own site rather than through a partner network. That's not a red flag, but it's why we'd tell you to confirm shipping to your state and read the refund terms yourself. For how we weigh these factors, see our scoring methodology.

Bottom line

Helios Meds does one thing well: it gets cost-conscious patients onto compounded semaglutide cheaply, with the consult and shipping included and a legitimate compliance credential behind it. The tirzepatide pricing is less competitive, the cash-pay-only model won't suit everyone, and the unpublished state list means you should verify coverage before you commit. But for a self-sufficient buyer chasing a low monthly price on compounded GLP-1 from a LegitScript-approved provider, it's a sensible, honest pick — just confirm the state availability and guarantee details before you pay.

Shopping around? SkinnyRx ($149.25/month) and bmiMD ($99/month) are the nearest alternatives to Helios Meds in our rankings.